BiotechTubeBiotechTube
Home/Atacama Therapeutics/Jonathan Reis
JR

Jonathan Reis

Co-Founder, Director, Head Corporate Development

Atacama Therapeutics

Therapeutic Areas

Dermatology

Atacama Therapeutics Pipeline

DrugIndicationPhase
AT-5214 (dexmecamylamine)Acne Vulgaris (moderate to severe)Phase 2
Early Stage ProgramsDermatology (unspecified)Preclinical

Leadership Team at Atacama Therapeutics

JB
Joseph Baron
Co-Founder, Director & CEO
MJ
Melissa Joseph
Head of CMC
GH
Garet Heintz
Head of Regulatory
BF
Barry Francis
Head of Quality Assurance
JR
John Ratcliffe
Interim CFO
DE
Dr. Esther Hong
Clinical Trial Investigator
DB
Dr. Benjamin Daniel
Clinical Trial Investigator
View full Atacama Therapeutics profile